Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

To identify a new regimen to optimize treatment for patients with newly diagnosed type 2 diabetes (T2DM) by short-term continuous subcutaneous insulin infusion (CSII) alone. Methods. 60 patients with newly diagnosed T2DM were randomized into two groups (n = 30 each) and treated for 2 weeks with CSII...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Heng, Zhao, Defu, Shen, Jie, Lu, Lu, Zhang, Tong, Chen, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698957/
https://www.ncbi.nlm.nih.gov/pubmed/26798658
http://dx.doi.org/10.1155/2016/9849328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698957/
https://www.ncbi.nlm.nih.gov/pubmed/26798658
http://dx.doi.org/10.1155/2016/9849328

Ejemplares similares